Search

Your search keyword '"Schultheiss, Christoph"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Schultheiss, Christoph" Remove constraint Author: "Schultheiss, Christoph"
220 results on '"Schultheiss, Christoph"'

Search Results

1. Ancestor regression in structural vector autoregressive models

2. Assessing the overall and partial causal well-specification of nonlinear additive noise models

3. SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition

4. Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

5. On the pitfalls of Gaussian likelihood scoring for causal discovery

6. On the Identifiability and Estimation of Causal Location-Scale Noise Models

7. Ancestor regression in linear structural equation models

8. Higher-order least squares: assessing partial goodness of fit of linear causal models

10. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells

12. Multicarving for high-dimensional post-selection inference

13. On the pitfalls of Gaussian likelihood scoring for causal discovery

17. Theoretical and experimental clues to a flux of Doppler transformation energies during processes with energy conservation

18. Transcriptomic, clonal, and functional analyses reveal Liver tissue-imprinted immuno-profile of circulating autoreactive CD4 T cells in autoimmune liver diseases

20. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells

22. A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors.

24. Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning.

25. Higher-Order Least Squares: Assessing Partial Goodness of Fit of Linear Causal Models.

28. Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial

29. Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma

30. SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system

33. Mutation-specific CAR T cells as precision therapy for IGLV3-21R110expressing high-risk chronic lymphocytic leukemia

35. Data from Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies

36. Supplementary Figures 1-3 and Table1 from Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies

38. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children

39. SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19

42. Translational analysis and final efficacy of the AVETUX trial – Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer

43. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19

44. Higher-order least squares: assessing partial goodness of fit of linear causal models

46. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma

47. The AI Neuropsychologist: Automatic scoring of memory deficits with deep learning

48. Automating clinical assessments of memory deficits: Deep Learning based scoring of the Rey-Osterrieth Complex Figure

50. Rapid Hypermutation B Cell Trajectory Recruits Previously Primed B Cells Upon Third SARS-Cov-2 mRNA Vaccination

Catalog

Books, media, physical & digital resources